StonvexLoading…
StonvexStonvexStonvexCore line items from BLIN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-12 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $4.79M | $7.83M | $3.91M | $15.38M | $11.51M |
Operating Income | Not available | $-597.00K | $-171.00K | $-2.43M | $-1.95M |
Net Income | Not available | $-518.00K | $-86.00K | $-2.52M | $-2.15M |
EPS (Diluted) | $0.00 | $-0.04 | $-0.01 | $-0.25 | $-0.23 |
Total Assets | Not available | $15.32M | $15.74M | $15.33M | $16.15M |
Total Liabilities | Not available | $6.09M | $6.18M | $5.76M | $6.20M |
Cash & Equivalents | Not available | $1.37M | $1.48M | $1.63M | $2.10M |
Free Cash Flow OCF − CapEx | Not available | $-103.00K | $-46.00K | $-1.12M | $-771.00K |
Shares Outstanding | Not available | 12.60M | 12.22M | 12.22M | 10.96M |